Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

SOHO 2026 Annual Meeting banner

IBCL - 549

Two-Year Rituximab Maintenance vs Observation After First-Line Treatment With Bendamustine Plus Rituximab (B-R) in Patients With Waldenström’s Macroglobulinemia: Results of a Prospective, Randomized Multicenter Phase 3 Study (StiL NHL7-2008 MAINTAIN Trial

Poster Presenter

Mathias Rummel

Part of Topic

Indolent B-Cell Lymphoma (IBCL)

TWO-YEAR RITUXIMAB MAINTENANCE VS OBSERVATION AFTER FIRST-LINE TREATMENT WITH BENDAMUSTINE PLUS RITUXIMAB (B-R) IN PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINEMIA: RESULTS OF A PROSPECTIVE, RANDOMIZED MULTICENTER PHASE 3 STUDY (STIL NHL7-2008 MAINTAIN TRIAL

Introduction

This mock abstract represents content that will later be loaded from the S3 object named soho2026.66d090a.Abstract.html.

Methods

The study summarizes conference submission metadata, authorship, affiliations, topic classification, presenter details, and linked poster media.

Conclusion

These placeholder sections preserve the detail-page structure while the production integration is connected to MySQL and S3.

soho2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.